Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 22.65B | 21.48B | 20.54B | 23.98B | 18.63B |
Gross Profit | 4.07B | 4.90B | 4.93B | 4.27B | 4.06B |
EBITDA | 5.17B | 3.96B | 3.64B | 5.64B | 6.61B |
Net Income | 2.81B | 2.26B | 1.11B | 4.95B | 3.90B |
Balance Sheet | |||||
Total Assets | 57.38B | 55.82B | 49.70B | 49.54B | 46.78B |
Cash, Cash Equivalents and Short-Term Investments | 4.16B | 5.65B | 2.68B | 3.49B | 3.22B |
Total Debt | 17.57B | 15.23B | 12.73B | 12.04B | 10.08B |
Total Liabilities | 31.75B | 31.63B | 28.57B | 27.36B | 26.53B |
Stockholders Equity | 25.67B | 23.89B | 20.82B | 21.84B | 19.96B |
Cash Flow | |||||
Free Cash Flow | 3.26B | 3.30B | 3.51B | 3.04B | 3.77B |
Operating Cash Flow | 3.39B | 3.52B | 3.90B | 3.39B | 4.02B |
Investing Cash Flow | -5.74B | -3.14B | -2.77B | 31.91M | -1.67B |
Financing Cash Flow | 803.86M | 2.70B | -1.92B | -2.88B | -1.79B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $6.09B | 4.10 | 26.38% | 2.39% | -4.14% | 13.02% | |
72 Outperform | $6.01B | 11.84 | 9.22% | 6.70% | -7.02% | 17.33% | |
71 Outperform | $6.01B | 10.78 | 9.22% | 6.89% | -7.02% | 17.33% | |
63 Neutral | HK$30.51B | 8.82 | 5.37% | 4.23% | -3.09% | 4.51% | |
61 Neutral | $9.62B | 7.38 | 29.79% | 5.19% | -3.22% | 141.11% | |
61 Neutral | $20.61B | 2,867.59 | 0.47% | 5.32% | 12.40% | -108.27% | |
52 Neutral | $1.84B | ― | -67.93% | ― | -7.58% | -819.97% |